News Focus
News Focus
icon url

buckysherm

12/13/16 11:08 PM

#8333 RE: Saltz #8317

That's a good justification for a possible expected buyout price. But wouldn't the new indications for cancer, lupus etc bring that up a bit ? Or isn't there enough time to move them far enough in trials to make a difference ?
icon url

Shane Chowdhury

12/14/16 3:10 AM

#8338 RE: Saltz #8317

Your words are precious.